Search
-
Estefania Calo Garcia
https://le.ac.uk/urban-history/study/visiting-scholar-scheme/estefania-calo-garcia
My name is Estefania Calo García, I am a PhD student at the Universidade da Coruña, in Galicia, Spain. I am a researcher of Sociology and the subject of my research is mainly about residential needs, urbanism and cities.
-
Senior management
https://le.ac.uk/about/who-we-are/senior-management
The Senior Management of the University is made up of the Executive Board, Senior Leadership Team, Academic Leadership Team, and Professional Services Executive Group.
-
Events
https://le.ac.uk/history/events
Find out about the upcoming events in the School of History.
-
Participants FAQs
https://le.ac.uk/ukags/participants/faqs
FAQ's for Participants who are part of UKAGS at The University of Leicester
-
Photography
https://le.ac.uk/graduation/on-the-day/photography
Find out information about photographs of your day.
-
Resources
https://le.ac.uk/vgec/topics/dna/dna-higher-education/resources
Resources on genetics for those studying to a degree level, supplied by The University of Leicester.
-
Undergraduate courses
https://le.ac.uk/film/study/undergraduate
At the University of Leicester you can explore Film Studies with experts from across the field. Find out more about our undergraduate degrees.
-
New guidance for filmmakers on how to represent people with disabilities
https://le.ac.uk/news/2023/june/disabilities-in-media
A recent PhD from the University of Leicester has called on the film industry to better represent people with disabilities on the big screen.
-
SIPRI
https://staffblogs.le.ac.uk/socscilibrarians/2013/06/21/sipri/
Posted by Andrew Dunn in Social Sciences and Humanities Librarians’ Blog on June 21, 2013 SIPRI Yearbook 2013 – f rom the Stockholm International Peace Research Institute (SIPRI).
-
Study seeking to find first medication for Long COVID welcomes first participant
https://le.ac.uk/news/2024/april/covid-medication
Researchers in Leicester have welcomed the first patient living with inflammatory Long COVID onto a study testing the effectiveness of tocilizumab at relieving their symptoms.